| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Aisling Capital II LP is a 10% Owner at Esperion Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $6.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 24, 2015 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Sell | 217,469 | $108.22 | $23,534,372.60 | -3.7% |